CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation
Jinju Park, Yiseul Choi, Young San Ko, Younghoon Kim, Jung-Soo Pyo, Bo Gun Jang, Min A Kim, Jae-Seon Lee, Mee Soo Chang, Jong-Wan Park, Byung Lan Lee
Cancer Research and Treatment. 2018;50(1):239-254.   Published online 2017 March 24    DOI: https://doi.org/10.4143/crt.2016.580

Excel Download

FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation
Cancer Research and Treatment. 2018;50(1):239-254   Crossref logo
Link1 Link2 Link3

Lapatinib
Reactions Weekly. 2018;1697(1):221-221   Crossref logo
Link1 Link2 Link3

miR-132 upregulation promotes gastric cancer cell growth through suppression of FoxO1 translation
Tumor Biology. 2015;37(12):15551-15557   Crossref logo
Link1 Link2 Link3 Link4

144 Alterations in Apoptosis-related Genes in Cell Line Models of Acquired Lapatinib Resistance, Identifies Potential Therapeutic Targets for the Treatment of Lapatinib Resistant HER2-positive Breast Cancer
European Journal of Cancer. 2012;48:44-45   Crossref logo
Link1 Link2

Autophagy facilitates the Lapatinib resistance of HER2 positive breast cancer cells
Medical Hypotheses. 2011;77(2):206-208   Crossref logo
Link1 Link2

Testican-1-mediated epithelial–mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer
Oncogene. 2013;33(25):3334-3341   Crossref logo
Link1 Link2 Link3

Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
Breast Cancer: Targets and Therapy. 2012;35   Crossref logo
Link1

Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy
Cancer. 2011;117(21):5013-5020   Crossref logo
Link1

Heregulin induces resistance to lapatinib-mediated growth inhibition of HER2-amplified cancer cells
Cancer Science. 2013;104(12):1618-1625   Crossref logo
Link1

143 MicroRNA-224 and −375 in Trastuzumab and Lapatinib Acquired and Innate Resistant HER2 Positive Breast Cancer Cells
European Journal of Cancer. 2012;48:44   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.